Tirzepatide
Tirzepatide Weight Loss
As the ol' saying goes, "weight loss is a marathon, not a sprint."
It can take time and effort, and there will be ups and downs.
Be patient with yourself, cultivate a positive mindset, and focus on creating sustainable, healthy habits!
​
We can help.
In a study of obese or overweight adults who did not have diabetes, participants taking Tirzepatide for 36 weeks lost an average of 20% of their body weight!
Tirzepatide Eligibility
Healthcare providers evaluate and identify people
most likely to benefit from Tirzepatide, including:
1. BMI/Obesity Status: Generally for adults with obesity (BMI of 30+) or those with overweight (BMI of 27+).
2. Presence of Type 2 Diabetes: It is not approved for those with Type 1 Diabetes.
3. Weight-Related Conditions: People without diabetes but with obesity-related risks (e.g. cardiovascular disease, sleep apnea, and more).
4. Prior Weight Management Efforts: Those who have tried other weight management options (e.g. diet, exercise, medications) without successful or sustainable results.
5. Medical History/Medications: Certain medications might interact with Tirzepatide or its effectiveness. Existing health issues, such as gastrointestinal problems or thyroid cancer history, may affect eligibility.
6. Commitment to Lifestyle Changes: Tirzepatide works best when combined with a healthy diet, an active lifestyle, and other modifications that support long-term weight management.
7. Ability to Manage Side Effects: Some may experience side effects, such as nausea or digestive issues.
8. Access to Follow-up Care
9. Age: Tirzepatide is approved for use in individuals 18 and over.
A thorough medical consultation is essential to ensure that
Tirzepatide is safe and appropriate for every candidate!
Studies have also indicated that Tirzepatide may offer health benefits beyond weight management, potentially improving blood pressure, reducing high cholesterol, and aiding blood sugar regulation. Guidance is essential to ensure successful integration into a comprehensive weight plan.
How Tirzepatide Works
When you eat, your digestive system releases two hormones:
-
GLP-1 (glucagon-like peptide-1): Helps release insulin to control blood sugar and signals the brain that you are full to reduce appetite.
-
GIP (gastric inhibitory polypeptide): Released by the small intestine to trigger insulin secretion and reduce appetite.
Tirzepatide mimics these hormones and activates their receptors. In turn, Tirzepatide increases insulin production after meals, slows digestion, and reduces hunger.
​
Unlike similar medications that only target GLP-1, Tirzepatide combines effects from both hormones, making it an effective treatment for managing Type 2 diabetes and promoting weight loss in those who are obese or overweight.
What is Tirzepatide?
-
Created as part of an ongoing effort to develop more effective treatments for Type 2 diabetes and obesity.
-
Rooted in the research on how certain hormones regulate blood sugar, appetite, and weight.
-
Designed to target two important hormones in the body, GLP-1 and GIP, to help control blood sugar levels and promote weight loss.
-
Approved under the brand name Mounjaro in 2022 to improve glycemic control in adults with Type 2 Diabetes Mellitus.
-
Known under the name Zepbound for weight loss purposes.
Almost 90% of patients who stayed on Tirzepatide maintained their weight loss, contrasting with those who stopped and experienced weight gain. A study released by the NIH found that once patients go off medications like Tirzepatide the average weight gain rebound is about two-thirds of the total weight loss during treatment.
